Antihypertensive therapy and the progression of renal disease

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Systemic hypertension accelerates the progression of glomerular injury. Studies in experimental animals indicate that the beneficial effects of antihypertensive agents may relate to their intrarenal haemodynamic consequences, and specifically to their effects on the arteriolar resistances. Relative afferent arteriolar vasodilation allows transmission of systemic pressure into the glomerular capillary network; the resultant glomerular capillary hypertension is associated with progressive structural injury. Antihypertensive agents, such as angiotensin converting enzyme (ACE) inhibitors, relax the efferent arteriole, alleviate glomerular hypertension and protect the kidney from progressive injury. These agents are effective in numerous animal models, and preliminary clinical observations suggest that they may also be effective in humans. In contrast, vasodilator/diuretic regimens are effective in some animal models, but fail to reduce glomerular pressure or injury in others. Less is known about the potential renal protective effects of calcium channel blockers, with reported observations offering conflicting findings. Further experimental and clinical studies are needed to define the optimal antihypertensive therapy for patients at risk of glomerular injury.

Original languageEnglish (US)
Pages (from-to)S39-S42
JournalJournal of Hypertension, Supplement
Volume7
StatePublished - 1989
Externally publishedYes

Fingerprint

Antihypertensive Agents
Disease Progression
Kidney
Wounds and Injuries
Hypertension
Animal Models
Therapeutics
Pressure
Calcium Channel Blockers
Arterioles
Vasodilator Agents
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Vasodilation
Hemodynamics

Keywords

  • Angiotensin converting enzyme inhibition
  • Chronic renal failure
  • Hypertension
  • Proteinuria
  • Renal haemodynamics

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Endocrinology

Cite this

Antihypertensive therapy and the progression of renal disease. / Anderson, Sharon.

In: Journal of Hypertension, Supplement, Vol. 7, 1989, p. S39-S42.

Research output: Contribution to journalArticle

@article{0bb75540675947ceb2c2b8fd7c51c1d6,
title = "Antihypertensive therapy and the progression of renal disease",
abstract = "Systemic hypertension accelerates the progression of glomerular injury. Studies in experimental animals indicate that the beneficial effects of antihypertensive agents may relate to their intrarenal haemodynamic consequences, and specifically to their effects on the arteriolar resistances. Relative afferent arteriolar vasodilation allows transmission of systemic pressure into the glomerular capillary network; the resultant glomerular capillary hypertension is associated with progressive structural injury. Antihypertensive agents, such as angiotensin converting enzyme (ACE) inhibitors, relax the efferent arteriole, alleviate glomerular hypertension and protect the kidney from progressive injury. These agents are effective in numerous animal models, and preliminary clinical observations suggest that they may also be effective in humans. In contrast, vasodilator/diuretic regimens are effective in some animal models, but fail to reduce glomerular pressure or injury in others. Less is known about the potential renal protective effects of calcium channel blockers, with reported observations offering conflicting findings. Further experimental and clinical studies are needed to define the optimal antihypertensive therapy for patients at risk of glomerular injury.",
keywords = "Angiotensin converting enzyme inhibition, Chronic renal failure, Hypertension, Proteinuria, Renal haemodynamics",
author = "Sharon Anderson",
year = "1989",
language = "English (US)",
volume = "7",
pages = "S39--S42",
journal = "Journal of Hypertension, Supplement",
issn = "0952-1178",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Antihypertensive therapy and the progression of renal disease

AU - Anderson, Sharon

PY - 1989

Y1 - 1989

N2 - Systemic hypertension accelerates the progression of glomerular injury. Studies in experimental animals indicate that the beneficial effects of antihypertensive agents may relate to their intrarenal haemodynamic consequences, and specifically to their effects on the arteriolar resistances. Relative afferent arteriolar vasodilation allows transmission of systemic pressure into the glomerular capillary network; the resultant glomerular capillary hypertension is associated with progressive structural injury. Antihypertensive agents, such as angiotensin converting enzyme (ACE) inhibitors, relax the efferent arteriole, alleviate glomerular hypertension and protect the kidney from progressive injury. These agents are effective in numerous animal models, and preliminary clinical observations suggest that they may also be effective in humans. In contrast, vasodilator/diuretic regimens are effective in some animal models, but fail to reduce glomerular pressure or injury in others. Less is known about the potential renal protective effects of calcium channel blockers, with reported observations offering conflicting findings. Further experimental and clinical studies are needed to define the optimal antihypertensive therapy for patients at risk of glomerular injury.

AB - Systemic hypertension accelerates the progression of glomerular injury. Studies in experimental animals indicate that the beneficial effects of antihypertensive agents may relate to their intrarenal haemodynamic consequences, and specifically to their effects on the arteriolar resistances. Relative afferent arteriolar vasodilation allows transmission of systemic pressure into the glomerular capillary network; the resultant glomerular capillary hypertension is associated with progressive structural injury. Antihypertensive agents, such as angiotensin converting enzyme (ACE) inhibitors, relax the efferent arteriole, alleviate glomerular hypertension and protect the kidney from progressive injury. These agents are effective in numerous animal models, and preliminary clinical observations suggest that they may also be effective in humans. In contrast, vasodilator/diuretic regimens are effective in some animal models, but fail to reduce glomerular pressure or injury in others. Less is known about the potential renal protective effects of calcium channel blockers, with reported observations offering conflicting findings. Further experimental and clinical studies are needed to define the optimal antihypertensive therapy for patients at risk of glomerular injury.

KW - Angiotensin converting enzyme inhibition

KW - Chronic renal failure

KW - Hypertension

KW - Proteinuria

KW - Renal haemodynamics

UR - http://www.scopus.com/inward/record.url?scp=0024894081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024894081&partnerID=8YFLogxK

M3 - Article

C2 - 2693656

AN - SCOPUS:0024894081

VL - 7

SP - S39-S42

JO - Journal of Hypertension, Supplement

JF - Journal of Hypertension, Supplement

SN - 0952-1178

ER -